Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting inflammatory diseases and oncology due to its ability to modify biological activity when incorporated into larger heterocyclic structures. Its bromine functionality allows for further cross-coupling reactions, enabling efficient derivatization in drug discovery programs. Commonly employed in research settings for the design of imidazopyridine-based therapeutics with improved selectivity and potency.